A study from Weill Cornell Medicine provides new insights into a pair of proteins and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver’s fight against tumors.
The findings could lead to new treatments targeting a particular protein to better manage inflammation in patients who don’t respond well to existing therapies.
A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, the Rockefeller University and the Icahn School of Medicine at Mount Sinai.
A study led by researchers at Weill Cornell Medicine and the New York Genome Center found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder cancer development.
The award funds innovative but inherently risky research endeavors that have the potential to overturn existing scientific paradigms or create new ones.
Weill Cornell Medicine researchers have found that removing protected class regulation from Medicare prescription drug policies could greatly reduce the United States' prescription drug spending, potentially saving $47 billion between 2011 and 2019.
Weill Cornell Medicine researchers found that the possibility of parental disclosure through online patient portals led older adolescents to hesitate in sharing complete health information with doctors.
